Spots Global Cancer Trial Database for EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy
Official Title: EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy
Study ID: NCT01493739
Interventions
Study Description
Brief Summary: This study aims on the combinatorial results of cytology, histopathology and microbiology obatined by EBUS-TBNA for unselected mediastina lesions.
Detailed Description: A number of studies have proved EBUS-TBNA to be useful for lymph node staging in lung cancer. The diagnostic performance is equivalent to mediastinoscopy while the invasiveness is far less. This study primarily focusing on merged approach of cytology, histopathology and microbioloogy obatined by EBUS-TBNA for unselected mediastina lesions.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chang Gung Memorial Hospital, Taipei, , Taiwan
Contact Details
Name: Chih-Hso Kuo, MD
Affiliation: Chang Gung Memorial Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
